In MS, serious adverse effects are more common in rituximab versus ocrelizumabSeptember 11, 2020Multiple Sclerosis
Blood biomarker may predict Parkinson’s disease progressionSeptember 10, 2020Parkinson's DiseaseMovement Disorders
Lowering rituximab dose in patients with MS proves safe and effectiveSeptember 9, 2020Multiple Sclerosis
Blood biomarkers could help predict when athletes recover from concussionsSeptember 4, 2020Traumatic Brain Injury
Multiple traits more common in difficult-to-treat patients with migraineAugust 13, 2020Headache & Migraine
Concussion linked to risk for dementia, Parkinson’s disease, and ADHDAugust 12, 2020Traumatic Brain InjuryParkinson's DiseaseAlzheimer's & Cognition
Consensus document reviews determination of brain deathAugust 12, 2020Alzheimer's & CognitionTraumatic Brain InjuryTrauma
